Soft Tissue Infections - PowerPoint PPT Presentation

1 / 38
About This Presentation
Title:

Soft Tissue Infections

Description:

... (furuncle) Antibiotics Always in high risk groups Controversial in healthy persons Sporotrichosis Mycotic infection Sporothrix schenckii Common in soil and on ... – PowerPoint PPT presentation

Number of Views:154
Avg rating:3.0/5.0
Slides: 39
Provided by: Tom1155
Learn more at: http://www.sjem.org
Category:

less

Transcript and Presenter's Notes

Title: Soft Tissue Infections


1
Soft Tissue Infections
  • Dr Cardinal

2
Objectives
  • Discuss the features of common skin infections as
    well as necrotizing skin infections including
  • Epidemiology
  • Pathophysiology
  • Clinical features
  • Treatment

3
Necrotizing Soft Tissue Infections
  • Gas gangrene (Clostridial myonecrosis)
  • Gas gangrene (Nonclostridial myonecrosis)
  • Streptococcal myositis
  • Necrotizing fasciitis (polymicrobial)
  • Necrotizing fasciitis ( Group A Streptococcus)
  • Necrotizing cellulitis

4
Gas Gangrene (Clostridial)
  • Epidemiology
  • About 1000 cases reported to CDC yearly
  • Pathophysiology
  • Seven sp Clostridium
  • C. perfringes 80-95
  • Soil, GI tract, Female GU
  • Release endotoxins
  • Cardiodepressant
  • Hydrolyzes cell membranes

C. perfringes
5
Gas Gangrene (Clostridial)
  • Clinical
  • Incubation 3 days
  • Pain out of proportion
  • Heaviness of affected part
  • Edema, brown discoloration
  • /- crepitance
  • Serosanguineous discharge
  • Bullae
  • Fever, tachycardia
  • Confusion, sepsis
  • Uterine myonecrosis after C-section
  • Deepest of the necrotizing soft tissue infections

6
Gas Gangrene (Clostridial)
  • Clinical
  • X-Ray/CT gas
  • Treatment
  • Resuscitation
  • Antibiotics
  • Pen G Clindamycin
  • Augmentin
  • Imipenem
  • Unasyn
  • Surgical debridement
  • Hyperbaric oxygen therapy (HBO)

7
Gas Gangrene (Nonclostridial)
  • Pathophysiology
  • Mixed infections
  • Aerobic / anaerobic
  • Bacteria by prevalence
  • Enterococcus
  • Staphylococcus
  • Alpha-Streptococci
  • E. coli
  • Klebsiella
  • Proteus
  • Bacteroides

E. Faecalis in blood culture
8
Gas Gangrene (Nonclostridial)

  • Clinical
  • Similar to Clostridial except
  • Pain at onset less
  • Delayed presentation (2-10 days)
  • Mortality 43

9
Gas Gangrene (Nonclostridial)
  • Treatment
  • Broad spectrum antibiotics
  • Aerobic gram / -
  • Anerobes
  • Unasyn
  • Timentin
  • Zosyn
  • Imipenem
  • Floroquinolone added if fresh water infection
    suspected
  • Surgical debridement
  • HBO

10
Streptococcal Myositis



  • Rare muscle infection
  • Group A Streptococcus
  • Usually S. pyogenes
  • flesh eating bacteria
  • Epidemiology
  • Age 20-50
  • Otherwise healthy

11
Streptococcal Myositis
  • Clinical
  • Difficult to distinguish from other myonecrosis
  • No gas production
  • High rate of bacteremia
  • Toxic shock syndrome 4-6 hours after admission
  • Mortality 80-100

12
Streptococcal Myositis
  • Treatment
  • Aggressive management of shock
  • Early vasopressors in shock
  • Antibiotics
  • IV Pen G / Clindamycin
  • IVIG 2g/kg
  • Neutralizes exotoxins
  • Surgical debridement

13
Necrotizing Fasciitis (Polymicrobial)
  • Necrosis of subQ and fascia
  • Does not spread to muscle as clostridial /
    nonclostridial myonecrosis
  • Also grouped into tabloid term flesh eating
    bacteria

14
Necrotizing Fasciitis (Polymicrobial)
  • Epidemology
  • 10-20 cases per 100,000 people
  • DM, PVD, IVDA, smoking
  • Pathophysiology
  • Mixed aerobic / anerobic
  • Average 4.4 organisms per infection
  • Usually antecedent trauma / bite
  • Bacteremia 25-30
  • Mortality 25-50

15
Necrotizing Fasciitis (Polymicrobial)
  • Clinical
  • Pain out of proportion
  • Erythematous / edematous
  • Discoloration, vesicles
  • Fever, tachycardia
  • May progress rapidly
  • Crepitus as late finding
  • Finger test

16
Necrotizing Fasciitis (Polymicrobial)
  • Treatment
  • Aggressive resuscitation
  • Avoidance of vasopressors
  • Antibiotics as in myonecrosis
  • Surgery
  • HBO

17
Necrotizing Fasciitis (Group A Streptococcus)
  • Epidemiology
  • 10-20 cases per 100,000
  • Mortality 20-60
  • Increased risk with
  • Varicella lesions
  • NSAID use

18
Necrotizing Fasciitis (Group A Streptococcus)
  • Clinical
  • Same as polymicrobial except
  • No gas formation
  • More rapid progression
  • More prone to bacteremia
  • Toxic shock more common

19
Necrotizing Fasciitis (Group A Streptococcus)
  • Treatment
  • Initial broad spectrum Abx
  • Narrowed to PCN and Clindamycin after culture
  • Clindamycin
  • Synergistic to PCN
  • Suppresses toxin formation
  • Promotes phagocytosis
  • Suppresses PCN
  • binding protein
  • HBO of little use (aerobic organism)

20
Necrotizing Cellulitis
  • Most superficial necrotizing soft tissue
    infection
  • Involves skin and subQ
  • Pathophysiology
  • Associated with antecedent trauma / bite
  • Common in skin popping
  • Usually polymicrobial
  • Clostridium most common
  • C. perfringens in trauma
  • C. septicum in malignancy and spontaneous
    infection

21
Necrotizing Cellulitis
  • Clinical
  • Pain at site. Less than seen in deeper infections
  • Eccymotic or necrotic center
  • Vesicles or blebs possible
  • Crepitence /-
  • Mild or no systemic symptoms

22
Necrotizing Cellulitis
  • Treatment
  • Surgical debridement (usually curative)
  • Broad spectrum abx

23
Cellulitis
  • Local soft tissue inflammation
  • from bacterial invasion
  • Epidemiology
  • 1.3 of ER vistis
  • 61 Male, Mean age 46
  • Usually extremities
  • Only 5 have predisposing factors

24
Cellulitis
  • Pathophysiology
  • Adults Staph/Strep spp. most common
  • Children H. influenza most common
  • Diabetics consider Enterobacteriaceae
  • Most bacterial organism cleared from body with 12
    hours. Majority of symptoms are from host immune
    response

25
Cellulitis
  • Clinical
  • Local inflammation, tenderness, warmth, erythema,
    induration
  • Lymphangitis uncommon concerning
  • Bacteremia uncommon in healthy hosts

26
Cellulitis
  • Treatment outpatient
  • Dicloxacillin
  • Macrolide
  • Azithromycin
  • Clarithromycin
  • Augmentin
  • Treatment inpatient
  • Involving head or neck
  • IV abx

27
Erysipelas
  • Superficial cellulitis with lymphatic involvement
  • Usually from Group A Streptococcus
  • Antecedent trauma / bite or dermatoses
  • Lower extremities now most common

28
Erysipelas
  • Clinical
  • Abrupt onset
  • High fever, chills, malaise and nausea prodrome
  • Area of erythema with burning develops over next
    2 days
  • Red, shiny, hot plaque, sharply demarcated

29
Erysipelas
  • Treatment usually inpatient
  • Pen G IV
  • Nafcillin
  • Rocephin
  • Augmentin
  • Imipenem in severe

30
Cutaneous Abscesses
  • Pathophysiology
  • Requires loss of skin integrity
  • Usually caused by common colonizers
  • Scalp/trunk/extremities
  • Staph aureus, epidermidis
  • Intriginous/perineal
  • E. coli, P. mirabilis
  • Axilla
  • P. mirabilis

31
Cutaneous Abscesses
  • Clinical
  • Swelling, tenderness, erythema
  • Fluctuance, induration, drainage
  • Systemic spread unusual in healthy
  • Lymphadenitis, fever

32
Cutaneous Abscesses
  • Specific abscesses
  • Bartholin gland abscess
  • Paronychia and felons
  • Hidradenitis suppurativa
  • Infected sebaceous cyst
  • Perirectal abscess
  • Pilonidal abscess

33
Cutaneous Abscesses
  • Staphylococcal abscesses
  • Continuum of severity
  • Folliculitis
  • Furuncle (boil)
  • Carbuncle

34
Cutaneous Abscesses
  • Treatment
  • Incision and drainage
  • Wide excision if necessary (furuncle)
  • Antibiotics
  • Always in high risk groups
  • Controversial in healthy persons

35
Sporotrichosis

  • Mycotic infection
  • Sporothrix schenckii
  • Common in soil and on vegetation
  • Thermally dimorphic
  • Traumatic inoculation

36
Sporotrichosis
  • Clinical
  • Incubation 3 weeks
  • Crusted ulcer or plaque
  • at site
  • Local lymphadenitis common
  • Skip lesions along lymphatics
  • Rarely systemic
  • Meningitis
  • Pulmonary

37
Sporotrichosis
  • Diagnosis
  • Clinically / History
  • Fungal cultures
  • Tissue biopsy
  • Treatment
  • Itraconazole for 6 months

38
Questions?
Write a Comment
User Comments (0)
About PowerShow.com